Hillord Pharmaceutical India Private Limited, a active private limited company, was established on 17 October 2013 in Namakkal, Tamil Nadu, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U51397TZ2013PTC019933. Registered under ROC Roc Coimbatore. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹1.00 Cr.
It upholds a compliant status. Its leadership includes Rangasamy Kiruthika (Director), Kandasamy Ranjith Kumar (Director), Saravanan Sengottaian (Director). Past directors included Nithya Palanisamy. It holds ₹2.20 Cr open charges and no settled loans. Its latest AGM occurred on 28 September 2018, with the balance sheet filed on 31 March 2018. It is based at 155/ 69A, Thuraiyur Main Road, Namakkal, Tamil Nadu, 637001.
U51397TZ2013PTC019933
019933
17 October 2013
₹1.00 Cr
₹1.00 Cr
Roc Coimbatore
Unlisted
Active
Explore comprehensive insights into Hillord Pharmaceutical India Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rangasamy Kiruthika | Director | 17 Oct 2013 | Current |
| Kandasamy Ranjith Kumar | Director | 17 Oct 2013 | Current |
| Saravanan Sengottaian | Director | 17 Oct 2013 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 23 Jan 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Hillord Pharmaceutical India Private Limited, for the financial year ended 2018, experienced significant growth in revenue, with a 99.4% increase. The company also saw a substantial improvement in profitability, with a 123.26% increase in profit. The company's net worth Soared by an impressive increase of 4301.4%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2018, Hillord Pharmaceutical India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹22,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Jun 2017 | Others | ₹2.20 Cr | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Hillord Pharmaceutical India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Hillord Pharmaceutical India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hillord Pharmaceutical India's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Hillord Pharmaceutical India Private Limited last Annual general meeting of members was held on 28 Sep 2018 as per latest MCA records. was documented.
Progress on Hillord Pharmaceutical India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2018 with Roc Coimbatore. was documented.
The activity A charge with Others amounted to Rs. 2.20 Cr with Charge ID 100114435 was registered on 28 Jun 2017. was completed.
Progress on Rangasamy Kiruthika was appointed as a Director was appointed as a Director on 17 Oct 2013 & has been associated with this company since 12 years 2 months . was documented.
Kandasamy Ranjith Kumar was appointed as a Director was appointed as a Director on 17 Oct 2013 & has been associated with this company since 12 years 2 months . was recorded as a recent event.
Progress on Saravanan Sengottaian was appointed as a Director was appointed as a Director on 17 Oct 2013 & has been associated with this company since 12 years 2 months . was documented.
The CIN of Hillord Pharmaceutical India Private Limited is U51397TZ2013PTC019933.
Hillord Pharmaceutical India Private Limited is headquartered at 155/ 69A, Thuraiyur Main Road, Namakkal, Tamil Nadu, 637001.
Hillord Pharmaceutical India Private Limited was incorporated on 17 October 2013.
The current directors of Hillord Pharmaceutical India Private Limited are
The primary industry of Hillord Pharmaceutical India Private Limited is Manufacturing.
Hillord Pharmaceutical India Private Limited is unlisted.
The authorized capital of Hillord Pharmaceutical India Private Limited is ₹1.00 Cr, and the paid-up capital is ₹1.00 Cr.
The compliance status of Hillord Pharmaceutical India Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX